Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation)-Reference-Cited by-同舟云学术

Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation)

Published:2018-01-08 Issue:1 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ostinelli Edoardo G¹,Jajawi Salwan²,Spyridi Styliani³⁴,Sayal Kamlaj⁵,Jayaram Mahesh B⁶

Affiliation:

1. Università degli Studi di Milano; Department of Health Sciences; Via Antonio di Rudinì 8 Milan Italy 20142

2. Rotherham, Doncaster and South Humber NHS Trust; Department of Psychiatry; Rotherham UK

3. Cyprus University of Technology; Department of Rehabilitation Sciences, Faculty of Health Sciences; 30 Archbishop Kyprianou Street Lemesos Cyprus 3036

4. Psychiatry - UK LLP; PO Box 329 Dewsbury West Yorkshire UK WF13 9DN

5. Cygnet Hospital Derby; Wyvern Locked Rehabilitation Unit; 100 City Gate London Road Derby UK DE24 8WZ

6. Melbourne Neuropsychiatry Centre; Department of Psychiatry; University of Melbourne Melbourne Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference137 articles.

1. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol;Andrezina;Psychopharmacology,2006

2. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study;Andrezina;Current Medical Research and Opinion,2006

3. Bristol-Myers S A randomized, double-blind comparison of the efficacy and safety of aripiprazole intramuscular formula, haloperidol, or placebo in the treatment of acutely agitated patients with a diagnosis of schizophrenia or schizoaffective disorder http://www.Clinicalstudyresults.org/ 2004

4. Citrome LL Vester-Blokland E Archibald D McQuade R Kostic D Pikalov A Benefits of a second dose of intramuscular (IM) aripiprazole to control agitation in patients with schizophrenia or bipolar I disorder Proceedings of the 159th Annual Meeting of the American Psychiatric Association; 2006 May 20-25; Toronto, Canada 2006

5. Currier GW Crandall D Archibald D Nyilas M Kostic D Pikalov A Intramuscular (IM) aripiprazole controls agitation in patients with schizophrenia or bipolar disorder without excessive sedation Proceedings of the 159th Annual Meeting of the American Psychiatric Association; 2006 May 20-25; Toronto, Canada 2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aripiprazole versus brexpiprazole for people with schizophrenia;Cochrane Database of Systematic Reviews;2023-02-17

2. Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice;Current Pharmaceutical Design;2022-08

3. Substance Abuse Associated with Aggressive/Violent Behaviors in Psychiatric Outpatients and Related Psychotropic Prescription;International Journal of Mental Health and Addiction;2022-05-23

4. Medicinal Chemistry Strategies for the Development of Bruton’s Tyrosine Kinase Inhibitors against Resistance;Journal of Medicinal Chemistry;2022-05-20

5. Which Emergent Medication Should I Give Next? Repeated Use of Emergent Medications to Treat Acute Agitation;Frontiers in Psychiatry;2021-12-07